Moreira, Alvaro

Immunology of COVID-19: Current State of the Science

Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,623

Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy

Moreira, A., Leisgang, W., Schuler, G., & Heinzerling, L. (2017) · Immunotherapy

Inflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and Biomarkers

Cited by 147

Checkpoint inhibitor-induced eosinophilic fasciitis following high eosinophilia associated with complete response

Toussaint, F., Hammon, M., Erdmann, M., Moreira, A., Kirchberger, M. C., Schuler, G., Schett, G., & Heinzerling, L. (2019) · Rheumatology

Cancer Immunotherapy and BiomarkersEosinophilic Disorders and Syndromes

Cited by 19